Certified by Founder Lodge
SolasCure
United Kingdom - Cambridge START UP
1 Disclosed Funding Rounds $13,422,000
0 Participating Investments
- Founded date
2017
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
SolasCure leverages biomimicry and evidence-based medicine to develop fit for purpose, efficacious wound care products significantly improve the health and wellbeing of patients.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 28 ,2023 | Series B | $13,422,000 |
Wealth Club
Seneca Partners
BRAIN Biotech AG
EVA pharma
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Further AI | $5,000,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
TwinKnowledge | $3,700,000 | (Apr 3, 2025)
